Driving Change in 2023: Our year in review

FDA approves Opill as the first OTC birth control pill in the United States!

Misoprostol-only resource hub: Highlighting its safety & effectiveness

Announcing the Support Unseen Podcast launch

Announcing the launch of Ibis's Africa Region Strategy for 2022-2025

Home

Evidence, Power, and Change drive our vision: 

A just, inclusive world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.

#IbisDrivesChange